TVTX earnings: real EPS beat/miss history, analyst consensus Buy, P/E -114.82. Updated 2026-07-23.
Travere Therapeutics (TVTX) Research Hub
Travere Therapeutics (TVTX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 66.17 USD (-0.08%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -114.82, market cap 5.17B. This hub links to the full technical, earnings and options research available for TVTX.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 66.17 USD (-0.08%) |
| 52-week range | 52.06 USD – 68.73 USD |
| Trend regime | Range |
| 14-day RSI | 68.5 (Bullish) |
| Trailing P/E | -114.82 |
| Market cap | 5.17B |
| Dividend yield | 0.00% |
Available research for TVTX
Covered Call on TVTX: how it works, illustrative setup around the real 66.17 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on TVTX: how it works, illustrative setup around the real 66.17 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on TVTX: how it works, illustrative setup around the real 66.17 USD price, max profit/loss, breakeven and when to use it. Educational.
TVTX technical analysis: range, last 66.17 USD, RSI 68.5, 52w range 52.06 USD–68.73 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is TVTX in?
Travere Therapeutics (TVTX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is TVTX in an uptrend or downtrend?
As of 2026-09-11, TVTX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is TVTX's trailing P/E ratio?
TVTX's trailing P/E is -114.82, with a market cap of 5.17B. See the earnings research page for full valuation detail.